The Medical and Surgical Practice of NaProTECHNOLOGY, 467-476, 2004
Chapter 37: Role of Compounding Pharmacist
Author affiliations
- Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Abstract
Compounding pharmacists prepare individualized hormone formulations — including HCG, progesterone, and thyroid preparations — that are central to NaProTECHNOLOGY treatment protocols, where standardized commercial doses are often inadequate for patient-specific needs. Collaborative prescribing between NaPro practitioners and licensed compounding pharmacists ensures consistent bioidentical formulation quality, dosing precision, and regulatory compliance within fertility and reproductive endocrine management.
Topics
RRM Methods > NaProTECHNOLOGY > ProtocolReproductive Endocrinology > Progesterone > SupplementationReproductive Endocrinology > Progesterone > PhysiologyReproductive Endocrinology > Estrogen > Clinical EffectsReproductive Endocrinology > Thyroid > TreatmentReproductive Endocrinology > Luteal Phase > SupportReproductive Endocrinology > Testosterone > SupplementationPerimenopause/Menopause > HRT > AlternativesPerimenopause/Menopause > HRT > RisksGeneral OB/GYN > Clinical Practice > StandardsEthics/Philosophy > RRM Philosophy > Clinical EthicsBody Literacy > Patient Empowerment > Informed Decision-MakingInfertility > Female Factor > Hormonal TreatmentInfertility > Male Factor > Hormonal
Cite this article
Hilgers, T. W., & Reed-Kane, D. (2004). Chapter 37: Role of Compounding Pharmacist. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 467-476.
Hilgers TW, Reed-Kane D. Chapter 37: Role of Compounding Pharmacist. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:467-476.
Hilgers, T. W., and D. Reed-Kane. "Chapter 37: Role of Compounding Pharmacist." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 467-476.